Qiming Medical-B (02500) issued an announcementjilionline, as of the date of this announcementjilionline, all remedial measures recommended by the internal control consultant are being implemented or have been completed. Therefore, after conducting a follow-up evaluation of the remedial measures implemented by the Group, the internal control consultant issued an internal control review report on May 8, 2024.
After considering the internal control review report and the remedial measures taken by the Company, the Audit Committee and the Board of Directors are of the view that the remedial measures implemented by the Company and its relevant subsidiaries (namely Qiming Hong Kong, Hangzhou Qijin, Qiming America and Hangzhou Qiyi) are sufficient to address the main findings of the internal control review, and that the strengthened internal control system can enable the Company to manage relevant risks to a reasonable level. Therefore, the Board of Directors believes that the Company has established sufficient internal control systems to fulfill its obligations under the Listing Rules.
In addition, the company's shares continued to be suspended.